{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

Global Energy Pressures Elevate the Importance of New Supply Frontiers

April 10, 2026NetworkNewsWire Editorial Coverage: Escalating geopolitical tensions and renewed disruptions to key shipping corridors, particularly around the Strait of Hormuz, are once again highlighting a persistent vulnerability: global energy security remains fragile. Despite years of diversification efforts, both the United States and Europe continue to face exposure to supply disruptions capable of cascading through economies, industries and households.


North Korean Cybercriminals Grab $285M from Crypto Exchange

April 10, 2026A group of hackers linked to North Korea has carried out one of the largest crypto thefts of the year, seizing roughly $285 million from a decentralized trading platform after quietly embedding themselves in its operations over several months. When licensed crypto companies like Circle Internet Group Inc.


China Starts Building Mega Solar Plant in Xizang

April 10, 2026China has broken ground on a large-scale solar installation in Xizang, extending its renewable energy push deep into one of the country’s most challenging environments. The facility is being developed on the Qinghai-Tibet Plateau, a location chosen for its energy potential rather than its convenience.


Intel Joins Elon Musk in Terafab Project

April 10, 2026Last month, Elon Musk announced an ambitious project that will produce semiconductors. According to his plans, the facility will be integrated and will perform all processes from designing the AI chips, making those chips, producing HBM memory and manufacturing advanced chip packaging solutions.


Immunotherapy Could Be Boosted by Blocking the Removal of Cancer RNA

April 10, 2026The immune system is capable of identifying and attacking cancer cells in the body. This process depends on the tumor producing damaged RNA, which then sticks to cell surfaces and provides the antigens that the body identifies as foreign and therefore targets.


Toyota’s bZ EV is Threatening Tesla’s Dominance in the US

April 10, 2026Toyota has quietly become one of the more consequential stories in the American electric vehicle market this year. Surging sales from its bZ crossover have placed the Japanese automaker in direct competition with Tesla for EV leadership, arriving at a moment when most rivals are retreating and pricing missteps have left the broader market exposed.


Is AI Dominance Being Shared Between the US and China?

April 10, 2026In the decades after World War II, competition between Washington and Moscow centered on nuclear weapons, drawing in top scientists on both sides. Today, the United States is engaged in a different contest, this time with China, focused on control of advanced technologies, especially AI.


Gold Stumbles as Iran War Escalation Looms

April 10, 2026The prices of gold and silver edged lower at the start of the week, though both metals retained most of the strong gains recorded over Easter Week. The pullback comes amid rising geopolitical tension, as President Donald Trump signaled a potential military escalation against Iran unless Tehran complies with demands to reopen the Strait of Hormuz by a newly set deadline.


MissionIRNewsBreaks – Linkers Industries Limited (NASDAQ: LNKS) Announces Full Exercise Of Series B Cashless Warrants

April 10, 2026Linkers Industries Limited (NASDAQ: LNKS), a Malaysia-based manufacturer and supplier of wire and cable harnesses, announced that all Series B cashless warrants issued in its March 2026 public offering have been fully exercised. Following the exercise and the company’s 250-for-1 reverse share split effective April 6, 2026, Linkers Industries now has 1,521,376 Class A ordinary shares and 250,000 Class B ordinary shares issued and outstanding, reflecting the completion of the zero exercise price warrant conversion tied to its approximately $16 million financing.


LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Accelerates Cancer Care Innovation with Liora Technologies Acquisition and Leadership Expansion

April 10, 2026 LIXT is advancing its lead compound LB-100 across different clinical programs aimed at difficult-to-treat cancers The company’s acquisition of Liora Technologies introduces a complementary therapy platform with recurring revenue potential These updates underscore LIXTE’s broader strategy: integrating drug development and med-tech innovation to redefine cancer treatment LIXTE Biotechnology (NASDAQ: LIXT) is executing a differentiated strategy in oncology, extending beyond traditional drug development into a more integrated and multi-dimensional approach to cancer care. With the company’s lead clinical candidate, LB-100, advancing through trials and the addition of Liora Technologies to its platform, they are positioning themselves at the nexus of pharmaceutical innovation and next-generation radiotherapy (ibn.


NetworkNewsBreaks – Greenland Energy Company (NASDAQ: GLND) Positioned In Push For Energy Security Amid Global Supply Risks

April 10, 2026Greenland Energy (NASDAQ: GLND) is emerging as a notable player in the global effort to strengthen energy security, according to NetworkNewsWire Editorial Coverage, as geopolitical tensions and disruptions to key shipping corridors, including the Strait of Hormuz, underscore ongoing vulnerabilities in global supply chains. With exploration activities focused on Greenland’s Jameson Land Basin, the company is advancing efforts to unlock potentially significant oil resources in a politically stable region, aligning with broader Western priorities to reduce reliance on volatile energy routes and enhance domestic supply resilience.


TechMediaBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured In AINewsWire Editorial On AI And Robotics In Pharma Manufacturing

April 10, 2026Nightfood Holdings (OTCQB: NGTF) announced its inclusion in an editorial published by AINewsWire, part of the Dynamic Brand Portfolio at IBN (InvestorBrandNetwork), highlighting the growing role of robotics and artificial intelligence in pharmaceutical manufacturing. The editorial outlines increasing regulatory pressure around contamination control, data integrity and traceability, noting that evolving standards such as the EU’s GMP Annex 1 are accelerating adoption of automation and AI-driven systems, while Nightfood, operating as TechForce Robotics, is advancing AI-enabled robotic platforms designed to support continuous compliance through autonomous functionality, SOP-based intelligence and real-time deviation detection.


BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured In AINewsWire Editorial On AI-Driven Pharma Manufacturing

April 10, 2026Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in an editorial published by AINewsWire, part of the Dynamic Brand Portfolio at IBN (InvestorBrandNetwork), highlighting the growing role of artificial intelligence in pharmaceutical manufacturing. The editorial underscores a sector-wide shift toward integrating AI directly into production workflows as a continuous compliance layer, enabling real-time monitoring, validation and optimization of processes to meet evolving Good Manufacturing Practice requirements, while positioning companies like Oncotelic at the intersection of biotechnology and advanced digital systems driving scalable efficiency and long-term cost advantages.